Abingworth
Working with entrepreneurs to turn breakthrough science into breakthrough medicine.
Since our first biotech investment over thirty years ago, Abingworth has helped young biopharma companies on both sides of the Atlantic turn the latest scientific discoveries into dozens of new treatments for patients.
That process requires time, patience, determination, experience and capital—all of which we provide to our portfolio companies. As the pace of life science research continues to increase, so does the flow of discoveries with the potential to yield new therapeutics. We look forward to working with the next generation of biopharma companies to convert that potential into reality.